Abstract: N-terminal pro b-type natriuretic peptide (NT-proBNP) was considered a prognostic factor for mortality in hemodialysis patients in previous studies. However, NT-proBNP has not been fully explored in terms of predicting other clinical outcomes in hemodialysis patients. This study aimed to investigate if NT-proBNP could predict emergency department (ED) visits, hospitalization, admission to intensive-care unit (ICU), and cardiovascular incidents in hemodialysis patients. Serum NT-proBNP and other indicators were collected in 232 hemodialysis patients. Patients were followed up for three years or until mortality. Outcomes included mortality, number of ED visits, hospitalizations, admissions to ICU, and cardiovascular events. NT-proBNP was found to predict recurrent ER visits, hospitalization, admission to ICU, cardiovascular events, and mortality, after adjusting for covariates. Time-dependent area under the curve (AUC) was used to evaluate the NT-proBNP predicting ability. Using time-dependent AUC, NT-proBNP has good predictive ability for mortality, ED visit, hospitalization, ICU admission, and cardiovascular events with the best predictive ability occurring at approximately 1 year, and 5th, 62nd, 63rd, and 63rd days respectively. AUC values for predicting mortality, hospitalization, and ICU admission decreased significantly after one year. NT-proBNP can be applied in predicting ED visits but is only suitable for the short-term. NT-proBNP may be used for predicting mortality in the long term.
Introduction
N-terminal pro b-type natriuretic peptide (NT-proBNP) has been widely used as a prognostic indicator in heart failure patients [1] . NT-proBNP is secreted in ventricles when an elevation in blood pressure is detected. This biomarker will also increase when patients are in decompensated bypass graft surgery (ICD-9-Procedure 36.1x), or percutaneous coronary intervention (ICD-9-Procedure 36.06, 36.07, 0.66) [15] .
Comorbidities of Interest
We reviewed patients' EMR and identified the following diagnoses as comorbidities: hypertension, hyperlipidemia, coronary artery disease, and diabetes. We also used prescription records, laboratory values, and vital signs data to identify these comorbidities in order to minimize potential underdiagnosis and undercoding. Specifically, individuals were classified as having hypertension if they had 2 or more blood pressure readings on different days in which their diastolic blood pressure reading was over 80, if their systolic blood pressure was over 130 during the study period, or if they received any antihypertensive medications [16] [17] [18] . Individuals were classified as having hyperlipidemia if they had 2 or more readings on different days in which their total cholesterol levels were over 200, low-density lipoprotein cholesterol levels were over 130, triglyceride levels were over 150, or high density lipoprotein cholesterol levels were under 60; or if they received any lipid-lowering medications. Coronary artery disease was defined as any evidence of coronary atherosclerotic plaque (obstructive or nonobstructive) on coronary angiography, ischemia on non-invasive cardiac testing, or past history of myocardial infarction/percutaneous coronary intervention/surgical revascularization. We defined patients as having diabetes based on a diagnosis of diabetes in medical records or as having receiving prescribed or redeemed blood glucose-lowering drugs.
Procedures
All patient's clinical or demographic characteristics were reviewed and collected. Blood testing was performed via venous sampling after overnight fasting. The plasma was separated and frozen at negative 70 degrees Celsius for further analysis. Venous sample was collected in the middle of the week before hemodialysis. The average follow-up time was 2.73 years.
Serum Analyses
Serum NT-proBNP was measured by enzyme-linked fluorescent assay (VIDAS NT-proBNP, bioMérieux, France) [19] . All other clinical biochemical parameters were measured by Siemens Dimension RxL system [20] .
Statistical Analysis
Non-normally distributed data were presented as median (interquartile (25th-75th percentiles) range), and normally distributed variables as mean ± SD. A Shapiro-Wilk test was performed to check normality of variables. Continuous variables normally distributed for each baseline NT-proBNP quartile were compared with analysis of variance (ANOVA) followed by the Bonferroni post hoc test. Categoric variables for each quartile were compared by chi-square test followed by Bonferroni test in multiple comparisons. Continuous variables not normally distributed compared with the Kruskal-Wallis test. Continuous variables tested for trend in each quartile were performed with linear trend test if variables were normally distributed, but with the Jonckheere-Terpstra test if variables were not normally distributed. Categorical variables tested for trend were performed with linear-by-linear trend test.
A Kaplan-Meier curve was used to summarize the survival distribution for all-cause mortality. A non-parametric, recurrent event survival curve was used to summarize the survival distribution for hospitalization, ED visits, ICU admission, and cardiovascular events [21] . More than three observation points were obtained from each patient. Recurrent event models were used to determine the relative hazard of recurrent events between NT-proBNP quartiles.
NT-proBNP values were logarithmically transformed before entering regression analysis for non-normally distributed data and are represented as lnBNP. The Andersen-Gill extension of the Cox proportional hazards model was used for multiple events per hemodialysis patient and in association with lnBNP as a time-varying covariable [22] . Covariates were selected by backward selection of models performed with the function stepAIC in the package MASS [23] . This approach removes covariates with the smallest contribution to model likelihood while penalising redundancy. The selection procedure terminated with a final model when removing any single covariate did not improve Akaike information criterion.
For the predictive ability of clinical outcomes at different time points, time-dependent receiver operating characteristic (survival ROC package, R language) was applied to display and compare the sensitivity and specificity of the predictive models based on the survival analysis [24] . A time-dependent area under the curve (AUC (t)) was also plotted to investigate the predictive accuracy on different time points. All p-values were two-tailed. A p-value of less than 0.05 was considered statistically significant. The SAS software Version 9.4 (SAS Institute Inc., Cary, NC, USA) and R software Version 2.6.1 (R Foundation for Statistical Computing, Vienna, Austria) with survival package were used.
Results

Patient Characteristics
Patients were grouped into quartiles according to their baseline NT-proBNP value. The percentages of coronary artery disease in Q3 and Q4 were higher than Q1 and Q2 (p = 0.005, Q1: 51.7%, Q2: 36.2%, Q3: 69%, Q4: 67.2%) ( Table 1 ). The trend test for percentages of coronary artery disease showed an increasing trend with increasing NT-proBNP quartiles (P-trend = 007). The proportion of patients in NYHA class III or IV was significantly greater in the Q3 and Q4 (45.7%, 26.1%) than in the Q1 and Q2 (15.2%, 13.0%) (p = 0.002). The trend test demonstrated the higher proportion of severe heart failure in increasing NT-proBNP quartile (P-trend = 0.001). Proportion of male participants was not significantly different between quartiles (p = 0.064), but revealed a linear trend with increasing quartiles with an increasing proportion of female participants (P-trend = 0.022). Kaplan-Meier estimates of 3-year mortality were significantly worse with increasing NT-proBNP quartiles of (Figure 1a ; log-rank test, p = 0.001). Recurrent ED visit, hospitalization, admission to ICU, and cardiovascular event were also compared among the four quartiles and revealed the same trend (Figure 1b -e; log-rank test, p < 0.0001). Number of each outcome event by NT-proBNP quartile was also listed in Table 2 . Increasing numbers in each outcome was demonstrated with increasing NT-proBNP quartiles. Kaplan-Meier estimates of 3-year mortality were significantly worse with increasing NT-proBNP quartiles of (Figure 1a ; log-rank test, p = 0.001). Recurrent ED visit, hospitalization, admission to ICU, and cardiovascular event were also compared among the four quartiles and revealed the same trend (Figures 1b-1e ; log-rank test, p < 0.0001). Number of each outcome event by NT-proBNP quartile was also listed in Table 2 . Increasing numbers in each outcome was demonstrated with increasing NT-proBNP quartiles. Andersen-Gill extension of the Cox proportional hazards model was used for revealing the effect of lnBNP on clinical outcomes. Age, serum C-reactive protein (CRP), albumin (ALB), were selected as covariates by backward selection by function stepAIC for model of total mortality. Mortality risk increased 1.54 for per unit of lnBNP increment (Table 3 , adjusted HR 1.54, CI: 1.08-2.19, p = 0.0158). Covariates selected by backward selection for model of ED visit included Age, systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), ALB, alanine aminotransferase (ALT), uric acid (UA), serum sodium (Na), serum potassium (K), serum phosphorus (P), hemoglobin (Hb), parathyroid hormone (PTH), ferritin, hypertension (HTN), coronary artery disease (CAD). Risk of ED visit increased 1.36 for per unit of lnBNP increment (Table  3, 
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Cardiovascular Events
For predicting cardiovascular events, the initial peak AUC value reached 0.9116 on the 25th day and dropped rapidly to 0.7698 on the 41st day. The AUC value remained stable around 0.6 thereafter ( Figure 6 ). 
Discussion
We aimed to investigate the predictive ability of NT-proBNP values in hemodialysis patients regarding different clinical outcomes. We found NT-proBNP can predict ED visit, hospitalization, ICU admission, cardiovascular event, and mortality after controlling for other covariates. Prediction ability of NT-proBNP assessed by time-dependent ROCs revealed that predicting ED visit is most accurate within a one-week time-frame, predicting cardiovascular events is suitable within one month, and predicting ICU admission and hospitalization is most accurate within two months. Predicting mortality is most accurate within one year, with an AUC of around 0.69.
NT-proBNP is also used to reflect glomerular filtration rate decrements in chronic kidney disease patients [25] , and the status of extracellular volume in addition to the magnitude of heart failure [26, 27] . NT-proBNP values were higher in our patients than in the heart failure patients of previous studies. Patients with higher NT-proBNP had higher percentage of coronary artery disease 
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Discussion
NT-proBNP is also used to reflect glomerular filtration rate decrements in chronic kidney disease patients [25] , and the status of extracellular volume in addition to the magnitude of heart failure [26, 27] . NT-proBNP values were higher in our patients than in the heart failure patients of previous studies.
Patients with higher NT-proBNP had higher percentage of coronary artery disease in our study (Q1: 51.7%, Q2: 36.2%, Q3: 69%, Q4: 67.2%, p = 0.005). The proportion of diabetes was not different among the four quartiles (p = 0.39). Gutiérrez et al. found that higher NT-proBNP values were associated with increased rates of coronary artery disease in end-stage renal disease patients, which is in line with our study [10] . A higher proportion of female participants was observed with higher NT-proBNP in our study (p = 0.064, P-trend = 0.022). Previous study also demonstrated gender have a significant influence on BNP levels [28] . They found females had a higher BNP value than males in the general population. The clinical significance of this finding deserved further investigation in the future for hemodialysis patients.
In our survival analysis (Figure 1 ), higher NT-proBNP was associated with higher risk for five clinical outcomes. A study by Paniagua et al. showed NT-proBNP can independently predict mortality even after controlling for other clinical factors [6] . Our study also revealed that our patients with higher NT-proBNP had lower survival probability (Figure 1a) . NT-proBNP remained an independent predictive factor of mortality even in multivariate Cox analysis (Table 3 , adjusted HR: 1.51, p = 0.031). NT-proBNP is used in the differential diagnosis of pulmonary and cardiac dyspnea among patients in ED [29, 30] . However, there are no previous studies about whether NT-proBNP can predict ED visit in hemodialysis patients. Our study revealed hemodialysis patients with higher NT-proBNP are more likely to visit the ED. (Figure 1b ) NT-proBNP was positively associated with ED visits in the multivariate Cox model (adjusted HR 1.35; 95% CI 1.15-1.58; p = 0.0001).
Hospitalization, ICU Admission, and Cardiovascular Events
NT-proBNP also provided valuable information to predict re-hospitalization associated with heart failure before discharge [31] . Verdiani et al. found higher NT-ProBNP values during hospital stay predict readmission [5] . Our data revealed that an increment of one unit in the NT-proBNP value will increase the chances of all-cause hospitalization 1.32-fold. Stolz et al. found BNP levels were significantly higher in patients requiring ICU treatment in a cohort of 208 chronic obstructive pulmonary disease patients older than 40 years [32] . Our study indicates hemodialysis patients with higher NT-proBNP will have increased risk of ICU admission after controlling for other factors in multivariate model (adjusted HR 1.46; 95% CI 1.13-1.88; p = 0.003). NT-proBNP values were able to predict the risk of cardiovascular events (HR 1.65; 95% CI 1.29-2.11; p < 0.0001). These results are in line with Tsuchida et al.'s findings which indicated BNP levels predicted the risk of cardiovascular events [33] .
Predictive Ability Over Time
Mortality
In the Masson et al. study, the AUC of NT-proBNP predicting 2-year all-cause mortality was 0.679 [34] , which is similar to the values of 0.690 and 0.710 found in our study for 2-and 3-year all-cause mortality, respectively. The predictive ability for 3-year mortality was relatively stable. In patients with dyspnea at admission to ED [35] , Januzzi et al. found that the AUC of predicting one-year mortality was 0.76. However, their study was based on dyspnea patients with heterogenous characteristics.
ED Visit
The ED visit predictive ability revealed the highest AUC of 0.808 at the 5th follow-up day and AUC dropped to 0.557 at one month. No known previous studies were performed to reveal the role of NT-proBNP in predicting ED; most studies focus on the role of NT-proBNP value at ED admission in differentiating dyspnea patients [36, 37] .
Predicting Hospitalization
The predictive ability of NT-proBNP remains controversial in some respects. Noveanu et al. used NT-proBNP to predict one-year hospitalization, but the AUC of NT-proBNP at presentation was only 0.49 (AUC: 0.49, CI: 0.34-0.63) [38] . Our study revealed that NT-proBNP can predict hospitalization up to 50 days (AUC: 0.81, CI: 0.75-0.87). The ability to predict hospitalization dropped to 0.6 after one year. Our findings are also compatible with the poor predictive ability found by Noveanu et al. [38] , in an evaluation made at the time of hospitalization. Using NT-proBNP to predict hospitalization in our study demonstrated the best predictive ability occurring at approximately the 50th day, which can be used to make a prognosis of the number of beds necessary at the department. High levels of BNP are also reported to be related to 1-and 6-month rehospitalization and mortality in patients with decompensated heart failure [39] [40] [41] .
Predicting ICU Admission
For the prediction of ICU admission, Krzych et al. revealed that preoperative assessment of NT-proBNP levels in coronary artery bypass graft patients could be a valuable diagnostic method for predicting several postoperative complications, especially pulmonary outcomes and the requirement for hemodynamic support; it was also correlated with the length of ICU stay. BNP level >190 pg/mL was a predictor of an ICU stay lasting >5 days [42] . Our study showed that NT-proBNP could predict ICU admission up to the 62nd day with an AUC of 0.9111 which gradually decreased thereafter.
Cardiovascular Events
Wolsk et al. noted that in patients with a recent acute coronary syndrome and type 2 diabetes mellitus, BNP significantly improved C-statistics when added to risk models for each outcome examined and for cardiovascular death in a two-year follow-up study [43] . The predictive ability of BNP combined with other risk factors to predict the incidence of cardioembolic stroke was excellent in in a general population in an 8-year follow-up was verified by Nakamura et al. [44] . NT-proBNP could predict cardiovascular events on the 25th day with a peak value of AUC reaching 0.9116, dropping rapidly to 0.7698 on the 41st day.
Limitations
We did not include intradialytic weight gain and ultrafiltration volume in our analysis. Causes of emergency room visits were not collected in our study. Mortality was not treated as a competing risk in our model. To learn more about how uremia per se affects the predictive ability of NT-proBNP, a similar study design including patients with or without uremic changes would have been optimal. The follow-up time was limited to 3 years in our study; therefore, any long-term predictive ability was not determined. Extrapolating conclusions from the present study to patients without dialysis should be done cautiously.
Conclusions
In hemodialysis patients, NT-proBNP is an important predictor of clinical outcomes including mortality, ED visit, hospitalization, ICU visit, and cardiovascular events. However, predicting ED visit is only suitable in the short-term. Mortality prediction was accurate within one year. Predicting hospitalization, ICU admission, and cardiovascular event was more accurate within 2 months. Further studies on the long-term utility of NT-proBNP in dialysis patients are needed. 
